These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

225 related items for PubMed ID: 15454346

  • 1. The role of endogenous cannabinoids in the hypothalamo-pituitary-adrenal axis regulation: in vivo and in vitro studies in CB1 receptor knockout mice.
    Barna I, Zelena D, Arszovszki AC, Ledent C.
    Life Sci; 2004 Oct 29; 75(24):2959-70. PubMed ID: 15454346
    [Abstract] [Full Text] [Related]

  • 2. Corticotropin-releasing hormone links pituitary adrenocorticotropin gene expression and release during adrenal insufficiency.
    Muglia LJ, Jacobson L, Luedke C, Vogt SK, Schaefer ML, Dikkes P, Fukuda S, Sakai Y, Suda T, Majzoub JA.
    J Clin Invest; 2000 May 29; 105(9):1269-77. PubMed ID: 10792002
    [Abstract] [Full Text] [Related]

  • 3. The kappa-opioid receptor agonist MR-2034 stimulates the rat hypothalamic-pituitary-adrenal axis: studies in vivo and in vitro.
    Calogero AE, Scaccianoce S, Burrello N, Nicolai R, Muscolo LA, Kling MA, Angelucci L, D'Agata R.
    J Neuroendocrinol; 1996 Aug 29; 8(8):579-85. PubMed ID: 8866244
    [Abstract] [Full Text] [Related]

  • 4. Alterations in hypothalamic-pituitary-adrenal axis activity and in levels of proopiomelanocortin and corticotropin-releasing hormone-receptor 1 mRNAs in the pituitary and hypothalamus of the rat during chronic 'binge' cocaine and withdrawal.
    Zhou Y, Spangler R, Schlussman SD, Ho A, Kreek MJ.
    Brain Res; 2003 Feb 28; 964(2):187-99. PubMed ID: 12576179
    [Abstract] [Full Text] [Related]

  • 5. The endogenous cannabinoid, anandamide, activates the hypothalamo-pituitary-adrenal axis in CB1 cannabinoid receptor knockout mice.
    Wenger T, Ledent C, Tramu G.
    Neuroendocrinology; 2003 Dec 28; 78(6):294-300. PubMed ID: 14688442
    [Abstract] [Full Text] [Related]

  • 6. Requirement of cannabinoid receptor type 1 for the basal modulation of hypothalamic-pituitary-adrenal axis function.
    Cota D, Steiner MA, Marsicano G, Cervino C, Herman JP, Grübler Y, Stalla J, Pasquali R, Lutz B, Stalla GK, Pagotto U.
    Endocrinology; 2007 Apr 28; 148(4):1574-81. PubMed ID: 17194743
    [Abstract] [Full Text] [Related]

  • 7. Evidence against a critical role of CB1 receptors in adaptation of the hypothalamic-pituitary-adrenal axis and other consequences of daily repeated stress.
    Rabasa C, Pastor-Ciurana J, Delgado-Morales R, Gómez-Román A, Carrasco J, Gagliano H, García-Gutiérrez MS, Manzanares J, Armario A.
    Eur Neuropsychopharmacol; 2015 Aug 28; 25(8):1248-59. PubMed ID: 26092203
    [Abstract] [Full Text] [Related]

  • 8. Chronic brain glucocorticoid receptor blockade enhances the rise in circadian and stress-induced pituitary-adrenal activity.
    van Haarst AD, Oitzl MS, Workel JO, de Kloet ER.
    Endocrinology; 1996 Nov 28; 137(11):4935-43. PubMed ID: 8895366
    [Abstract] [Full Text] [Related]

  • 9. Rapid alteration of stress-induced hypothalamic-pituitary-adrenal hormone secretion in the rat: a comparison of glucocorticoids and cannabinoids.
    Ginsberg AB, Pecoraro NC, Warne JP, Horneman HF, Dallman MF.
    Stress; 2010 May 28; 13(3):248-57. PubMed ID: 20392196
    [Abstract] [Full Text] [Related]

  • 10. The muscarinic cholinergic agonist arecoline stimulates the rat hypothalamic-pituitary-adrenal axis through a centrally-mediated corticotropin-releasing hormone-dependent mechanism.
    Calogero AE, Kamilaris TC, Gomez MT, Johnson EO, Tartaglia ME, Gold PW, Chrousos GP.
    Endocrinology; 1989 Nov 28; 125(5):2445-53. PubMed ID: 2551652
    [Abstract] [Full Text] [Related]

  • 11. Hypothalamic-pituitary-adrenocortical axis changes in a transgenic mouse with impaired glucocorticoid receptor function.
    Karanth S, Linthorst AC, Stalla GK, Barden N, Holsboer F, Reul JM.
    Endocrinology; 1997 Aug 28; 138(8):3476-85. PubMed ID: 9231802
    [Abstract] [Full Text] [Related]

  • 12. Acute glucocorticoid pretreatment suppresses stress-induced hypothalamic-pituitary-adrenal axis hormone secretion and expression of corticotropin-releasing hormone hnRNA but does not affect c-fos mRNA or fos protein expression in the paraventricular nucleus of the hypothalamus.
    Ginsberg AB, Campeau S, Day HE, Spencer RL.
    J Neuroendocrinol; 2003 Nov 28; 15(11):1075-83. PubMed ID: 14622438
    [Abstract] [Full Text] [Related]

  • 13. Stimulation of the hypothalamo-pituitary-adrenal axis in the rat by the type 4 phosphodiesterase (PDE-4) inhibitor, denbufylline.
    Hadley AJ, Kumari M, Cover PO, Osborne J, Poyser R, Flack JD, Buckingham JC.
    Br J Pharmacol; 1996 Oct 28; 119(3):463-70. PubMed ID: 8894165
    [Abstract] [Full Text] [Related]

  • 14. Impact of Hydrocortisone and of CRH Infusion on the Hypothalamus-Pituitary-Adrenocortical Axis of Septic Male Mice.
    Téblick A, De Bruyn L, Van Oudenhove T, Vander Perre S, Pauwels L, Derde S, Langouche L, Van den Berghe G.
    Endocrinology; 2022 Jan 01; 163(1):. PubMed ID: 34698826
    [Abstract] [Full Text] [Related]

  • 15. Cannabinoid receptor type 1 antagonism significantly modulates basal and loud noise induced neural and hypothalamic-pituitary-adrenal axis responses in male Sprague-Dawley rats.
    Newsom RJ, Osterlund C, Masini CV, Day HE, Spencer RL, Campeau S.
    Neuroscience; 2012 Mar 01; 204():64-73. PubMed ID: 22138156
    [Abstract] [Full Text] [Related]

  • 16. Novel in vitro perfusion system for the determination of hypothalamic-pituitary-adrenal axis responses.
    Moidel MA, Belz EE, Czambel RK, Rubin RT, Rhodes ME.
    J Pharmacol Toxicol Methods; 2006 Mar 01; 53(3):264-71. PubMed ID: 16311047
    [Abstract] [Full Text] [Related]

  • 17. Ghrelin regulates the hypothalamic-pituitary-adrenal axis and restricts anxiety after acute stress.
    Spencer SJ, Xu L, Clarke MA, Lemus M, Reichenbach A, Geenen B, Kozicz T, Andrews ZB.
    Biol Psychiatry; 2012 Sep 15; 72(6):457-65. PubMed ID: 22521145
    [Abstract] [Full Text] [Related]

  • 18. Regulatory mechanism of hypothalamo-pituitary-adrenal (HPA) axis and neuronal changes after adrenalectomy in type 2 diabetes.
    Yi SS, Hwang IK, Shin JH, Choi JH, Lee CH, Kim IY, Kim YN, Won MH, Park IS, Seong JK, Yoon YS.
    J Chem Neuroanat; 2010 Oct 15; 40(2):130-9. PubMed ID: 20472052
    [Abstract] [Full Text] [Related]

  • 19. Mechanisms of serotonin receptor agonist-induced activation of the hypothalamic-pituitary-adrenal axis in the rat.
    Calogero AE, Bagdy G, Szemeredi K, Tartaglia ME, Gold PW, Chrousos GP.
    Endocrinology; 1990 Apr 15; 126(4):1888-94. PubMed ID: 2156670
    [Abstract] [Full Text] [Related]

  • 20. Activation of the hypothalamo-pituitary-adrenal axis by the growth hormone (GH) secretagogue, GH-releasing peptide-6, in rats.
    Thomas GB, Fairhall KM, Robinson IC.
    Endocrinology; 1997 Apr 15; 138(4):1585-91. PubMed ID: 9075719
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.